MJID MAJESTIC IDEAL HLDGS LTD

Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting

Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting

HONG KONG, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Ltd (NASDAQ: MJID) (the “Company”) announced that during the Extraordinary General Meeting of Shareholders (the “Meeting”) held today at 11:00 a.m. at the Company’s office located at 7/F, China United Plaza, 1002-1008, Tai Nan West Street, Cheung Sha Wan, Kowloon, Hong Kong, the proposal to change the Company’s name was officially approved subject to and conditional upon the approval of the Registrar of Companies in the Cayman Islands.

The Meeting was duly convened, and Ms. Ll, Yuk Yin Judy, acting as the Chairperson of the Meeting in accordance with the Company’s Articles of Association, declared the Meeting open and confirmed that the quorum requirement was met.

Resolutions Passed

The Meeting deliberated and unanimously approved the following special resolutions:

Change of Company Name

The Company’s English name will be changed from “Majestic Ideal Holdings Ltd” to “Ping An Biomedical Co., Ltd.”

The Company’s Chinese name will be changed from “威美控股有限公司” to “平安生物医药有限公司”.

The name change will take effect upon the date of entry of the new English name and the dual foreign name in Chinese of the Company on the register maintained by the Registrar of Companies in the Cayman Islands and the date on which the certificate of incorporation on change of name is issued by the Registrar of Companies in the Cayman Islands.

Authorization to Implement Name Change

The Meeting authorized any one director, the secretary, and/or the registered office provider of the Company to notify the Cayman Islands Registrar of Companies of the special resolutions, complete all necessary filings, and take any actions required to implement the name change.

Both special resolutions were approved by a majority of at least two-thirds of shareholders being entitled to vote and present in person or by proxy at the Meeting.

Company Statement

The Board of Directors believes that the approved name change will enhance the Company’s corporate image and align with its strategic focus on biomedical and healthcare technologies. The Company remains committed to driving innovation and positioning itself as a leader in the industry.

About Majestic Ideal Holdings Ltd

Majestic Ideal Holdings Ltd is a one-stop SCM service provider in the apparel industry. It is also a forward-thinking company dedicated to delivering innovative solutions in healthcare and biomedical technology. The proposed name change reflects its commitment to advancing its mission and positioning itself as a leader in the industry.



For more information, please contact:
Celestia Investor Relations
Email:  
EN
12/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MAJESTIC IDEAL HLDGS LTD

 PRESS RELEASE

Ping An Biomedical Co., Ltd Announces Strategic Investment in Future B...

Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the “Investment Memorandum”) with Future Biotechnology Group Co., Ltd (hereinafter referred to as “Future Biotechnology Group”). The Investment Memorandum outlines an initial investment of US$30 million to be paid in cash, as well as subseque...

 PRESS RELEASE

Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leadin...

Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) today announced that it has entered into a series of share purchase agreements with several investors. Ping An Biomedical Co., Ltd. has entered into a series of share purchase agreements from several investors: Yao Jinbo, Chairman and CEO of 58 Group Inc.; Wang Donghui, Founder and Managing Partner of Amiba Capital Co....

 PRESS RELEASE

Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid P...

Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the “Company”) today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On November 24, 2025, Ping An Biomedical Co., Ltd. (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from October 10, 2025 to November 20, 2025, the Company no longer meets the...

 PRESS RELEASE

Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping...

Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting HONG KONG, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Ltd (NASDAQ: MJID) (the “Company”) announced that during the Extraordinary General Meeting of Shareholders (the “Meeting”) held today at 11:00 a.m. at the Company’s office located at 7/F, China United Plaza, 1002-1008, Tai Nan West Street, Cheung Sha Wan, Kowloon, Hong Kong, the proposal to change the Company’s name was officially approved subject to and conditional upon the approval of the Re...

 PRESS RELEASE

Majestic Ideal Holdings Limited Announced Closing of Initial Public Of...

Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Limited (Nasdaq: MJID) (the “Company”), a provider of SCM services in the apparel industry delivering one-stop solution, today announced the closing of its initial public offering (the “Offering”) of 2,500,000 ordinary shares (the “Ordinary Shares”) at a price of $6.00 per Ordinary Share. The Ordinary Shares began trading on the Nasdaq Capital Market on July 18, 2025 under the symbol “MJID.” The aggregate gross proceeds from the Offering were $1...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch